By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Immune Pharmaceuticals, Inc. 

150 Broadway
Suite 1801
New York  New York  10038  U.S.A.
Phone: 646-937-1941 Fax: n/a




Company News
Immune Pharma Announces Initiation Of Enrollment In Clinical Trial With Ceplene/ Low-Dose IL-2 In Chronic Myelomonocytic Leukemia (CMML) 6/20/2017 7:30:35 AM
Immune Pharma Receives NASDAQ Compliance Letter 6/19/2017 9:35:14 AM
Immune Pharma Signs Agreement To Regain Worldwide Rights For Ceplene 6/15/2017 8:35:16 AM
Immune Pharma Receives Nasdaq Letters 5/30/2017 6:52:42 AM
Immune Pharma Announces Private Placement Of Up To $3.4 Million 5/4/2017 7:59:45 AM
Immune Pharma Receives Nasdaq Letter 4/24/2017 11:22:03 AM
Immune Pharma CEO Steps Down to Lead R&D in Restructuring, May Spin Off Oncology Unit 4/24/2017 7:07:00 AM
Immune Pharma Signs Letter Of Intent With Pint Pharma Regarding License And Commercializion Of Ceplene In Latin America 4/20/2017 6:32:08 AM
Immune Pharma Announces 1-for-20 Reverse Stock Split 4/12/2017 10:10:15 AM
Immune Pharma Granted Additional Time To Comply With Nasdaq Listing Requirement 3/13/2017 10:46:27 AM